Lassen Therapeutics
Home - Lassen
- Business Model
- B2B
- Website
- lassentherapeutics.com
- Total Funding
- $85.0M
- Last Round
- $85.0M Series BDec 2023
- Rounds
- 1
About
Lassen Therapeutics is combining novel biology with industry-leading technologies to discover and develop a pipeline of biotherapeutics against compelling new targets that are central to diseases with significant unmet needs. The company generates high-quality antibodies with excellent pharmaceutical properties and collaborates with leading academic and industry partners to translate new science into medicines for patients.
Summary
Lassen Therapeutics is a Biotech company. It has raised $85.0M in total across 1 round, most recently a $85.0M Series B round in Dec 2023. Investors include Catalio Capital Management, Alta Partners and Longwood Fund.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2023
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lassen-therapeutics"><img src="https://indexed.vc/api/badge/company/lassen-therapeutics" alt="Lassen Therapeutics on Indexed.vc" width="260" height="76" /></a>